Fentanyl Infusion Is Effective in the Treatment of Dyspnea in End-Stage Heart Failure With Renal Failure: A Case Report

被引:0
作者
Sakamoto, Ryo [1 ]
Koyama, Atsuko [1 ]
机构
[1] Kindai Univ, Fac Med, Psychosomat Med, Osakasayama City, Japan
关键词
dyspnea; end-stage heart failure; palliative care; fentanyl;
D O I
10.7759/cureus.12673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with end-stage heart failure may require hospitalization for the treatment of respiratory distress. Morphine may be used to relieve symptoms. However, use of morphine is problematic because heart failure is often associated with renal dysfunction. In this case report, intravenous fentanyl infusion reduced dyspnea in a patient with end-stage heart failure who was on dialysis induction to treat renal failure. The patient was able to eat and sleep after administration of an intravenous fentanyl solution and experienced no apparent respiratory depression as a side effect of fentanyl. There have been few reports of dyspnea relief with fentanyl infusion. Because of its adjustable duration of effect, intravenous fentanyl may be a more effective and useful option than rapid or extended- release agents in cases such as this one.
引用
收藏
页数:4
相关论文
共 10 条
  • [1] Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study
    Currow, David C.
    McDonald, Christine
    Oaten, Sheila
    Kenny, Bernadette
    Allcroft, Peter
    Frith, Peter
    Briffa, Michael
    Johnson, Miriam J.
    Abernethy, Amy P.
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 42 (03) : 388 - 399
  • [2] Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients: A Cohort Analysis
    Diez-Quevedo, Crisanto
    Lupon, Josep
    de Antonio, Marta
    Domingo, Mar
    Martin-Subero, Marta
    Rangil, Teresa
    Moliner, Pedro
    Zamora, Elisabet
    Altimir, Salvador
    Santesmases, Javier
    Isabel Troya, Maria
    Boldo, Maria
    de Pablo, Joan
    Bayes-Genis, Antoni
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2018, 87 (06) : 372 - 374
  • [3] Depression, antidepressants, and long-term mortality in heart failure
    Diez-Quevedo, Crisanto
    Lupon, Josep
    Gonzalez, Beatriz
    Urrutia, Agustin
    Cano, Lucia
    Cabanes, Roser
    Altimir, Salvador
    Coll, Ramon
    Pascual, Teresa
    de Antonio, Marta
    Bayes-Genis, Antoni
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1217 - 1225
  • [4] Delirium in elderly people
    Inouye, Sharon K.
    Westendorp, Rudi G. J.
    Saczynski, Jane S.
    [J]. LANCET, 2014, 383 (9920) : 911 - 922
  • [5] The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis
    Maslej, Marta M.
    Bolker, Benjamin M.
    Russell, Marley J.
    Eaton, Keifer
    Durisko, Zachary
    Hollon, Steven D.
    Swanson, G. Marie
    Thomson, J. Anderson, Jr.
    Mulsant, Benoit H.
    Andrews, Paul W.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (05) : 268 - 282
  • [6] The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study
    Pilkey, Jana
    Pedersen, Allison
    Tam, James W.
    Malik, Amrit
    Wong, Jonathan
    [J]. JOURNAL OF PALLIATIVE CARE, 2019, 34 (02) : 96 - 102
  • [7] Fentanyl Formulations in the Management of Pain: An Update
    Schug, Stephan A.
    Ting, Sonya
    [J]. DRUGS, 2017, 77 (07) : 747 - 763
  • [8] Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review
    Simon, Steffen T.
    Koeskeroglu, Peyla
    Gaertner, Jan
    Voltz, Raymond
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 46 (06) : 874 - 886
  • [9] Palliative Care in Heart Failure
    Sood A.
    Dobbie K.
    Wilson Tang W.H.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2018, 20 (5)
  • [10] Prevalence and Importance of Comorbidities in Patients With Heart Failure
    Filippos K. Triposkiadis
    John Skoularigis
    [J]. Current Heart Failure Reports, 2012, 9 (4) : 354 - 362